Efficacy of immunotherapy based on skin end-point titration

Otolaryngology - Head and Neck Surgery

Volumn 123, Issue 3, 2000, Pages 183-187

  Krouse, John H ^a   Krouse, Helene J ^b  

^a Dick Holland Regenerative Medicine Program   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF NURSING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLERGIC RHINITIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; HUMAN; IMMUNOTHERAPY; NOSE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SKIN TEST; TREATMENT OUTCOME;

EID: 0033812684     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhn.2000.106194     Document Type: Article

References (10)

1. A standardized, quantitative skin-test assay of allergen potency and stability: Studies on the allergen dose-response curve and effect of wheal, erythema, and patient selection on assay results
2. History of skin testing and evolution of skin endpoint titration
3. Relief of hayfever by intradermal injections of pollen extract
4. The management of clinical allergy. Part II, etiologic factors and skin titration
5. Skin endpoint titration. Still the standard?
6. Council on Scientific Affairs (AMA). In vivo diagnostic testing and immunotherapy for allergy
7. The development of the Rhinosinusitis Disability Index
8. Psychometric and clinimetric validity of the 31-item rhinosinusitis outcome measure (RSOM31)
9. Patient use of traditional and complementary therapies in treating rhinosinusitis prior to consulting an otolaryngologist
10. Mediator release after nasal airway challenge with allergen